George M. Yousef, Ph.D. - Publications

Affiliations: 
2002 University of Toronto, Toronto, ON, Canada 
Area:
Medicine and Surgery

206 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Pampalakis G, Zingkou E, Sidiropoulos KG, Diamandis EP, Zoumpourlis V, Yousef GM, Sotiropoulou G. Biochemical pathways mediated by KLK6 protease in breast cancer. Molecular Oncology. PMID 30980596 DOI: 10.1002/1878-0261.12493  1
2019 Wang C, Ding Q, Plant P, Basheer M, Yang C, Tawedrous E, Krizova A, Boulos C, Farag M, Cheng Y, Yousef GM. Droplet digital PCR improves urinary exosomal miRNA detection compared to real-time PCR. Clinical Biochemistry. PMID 30905583 DOI: 10.1016/j.clinbiochem.2019.03.008  0.36
2018 Di Meo A, Wang C, Cheng Y, Diamandis EP, Yousef GM. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer. Biological Chemistry. PMID 29604203 DOI: 10.1515/hsz-2018-0112  1
2018 Reuning U, Magdolen V, Courty Y, Clements JA, Yousef GM, Scorilas A, Talieri M, Diamandis EP. Manfred Schmitt (1947-2018). Biological Chemistry. PMID 29601294 DOI: 10.1515/hsz-2018-0184  1
2018 Meo AD, Saleeb R, Wala SJ, Khella HW, Ding Q, Zhai H, Krishan K, Krizova A, Gabril M, Evans A, Brimo F, Pasic MD, Finelli A, Diamandis EP, Yousef GM. A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization. Oncotarget. 9: 2092-2104. PMID 29416756 DOI: 10.18632/oncotarget.23162  1
2017 Di Meo A, Bartlett J, Cheng Y, Pasic MD, Yousef GM. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Molecular Cancer. 16: 80. PMID 28410618 DOI: 10.1186/s12943-017-0644-5  0.56
2017 Khella HW, Daniel N, Youssef L, Scorilas A, Nofech-Mozes R, Mirham L, Krylov SN, Liandeau E, Krizova A, Finelli A, Cheng Y, Yousef GM. miR-10b is a prognostic marker in clear cell renal cell carcinoma. Journal of Clinical Pathology. PMID 28360191 DOI: 10.1136/jclinpath-2017-204341  0.76
2016 Wang C, Zhang W, Zhang L, Chen X, Liu F, Zhang J, Guan S, Sun Y, Chen P, Wang D, Un Nesa E, Cheng Y, Yousef GM. miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2. British Journal of Cancer. PMID 27832663 DOI: 10.1038/bjc.2016.367  0.36
2016 Fendler A, Stephan C, Yousef GM, Kristiansen G, Jung K. The translational potential of microRNAs as biofluid markers of urological tumours. Nature Reviews. Urology. PMID 27804986 DOI: 10.1038/nrurol.2016.193  0.6
2016 White-Al Habeeb N, Kulasingam V, Diamandis EP, Yousef GM, Tsongalis GJ, Vermeulen L, Zhu Z, Kamel-Reid S. The Use of Targeted Therapies for Precision Medicine in Oncology. Clinical Chemistry. PMID 27679436 DOI: 10.1373/clinchem.2015.247882  1
2016 Matin F, Jeet V, Clements JA, Yousef GM, Batra J. MicroRNA Theranostics in Prostate Cancer Precision Medicine. Clinical Chemistry. PMID 27540032 DOI: 10.1373/clinchem.2015.242800  1
2016 Di Meo A, Batruch I, Yousef AG, Pasic MD, Diamandis EP, Yousef GM. An integrated proteomic and peptidomic assessment of the normal human urinome. Clinical Chemistry and Laboratory Medicine. PMID 27394047 DOI: 10.1515/cclm-2016-0390  1
2016 Saleeb R, Faragalla H, Yousef GM, Stewart R, Streutker CJ. Malignancies in a renal transplant population: The St. Michael's Hospital experience. Urology Annals. 8: 163-7. PMID 27141185 DOI: 10.4103/0974-7796.165712  1
2016 Di Meo A, Pasic MD, Yousef GM. Proteomics and peptidomics: moving toward precision medicine in urological malignancies. Oncotarget. PMID 27119500 DOI: 10.18632/oncotarget.8931  1
2016 Sidiropoulos KG, Ding Q, Pampalakis G, White NM, Boulos P, Sotiropoulou G, Yousef GM. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes. Molecular Oncology. PMID 27093921 DOI: 10.1016/j.molonc.2016.03.008  1
2016 Ibrahim R, Pasic M, Yousef GM. Omics for personalized medicine: defining the current we swim in. Expert Review of Molecular Diagnostics. 1-4. PMID 26959799 DOI: 10.1586/14737159.2016.1164601  1
2016 Nofech-Mozes R, Khella HW, Scorilas A, Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans A, Yousef GM. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Medicine. 5: 656-64. PMID 26860079 DOI: 10.1002/cam4.631  1
2016 Wegman DW, Ghasemi F, Stasheuski AS, Khorshidi A, Yang BB, Liu SK, Yousef GM, Krylov SN. Achieving Single-Nucleotide Specificity in Direct Quantitative Analysis of Multiple microRNAs (DQAMmiR). Analytical Chemistry. PMID 26756139 DOI: 10.1021/acs.analchem.5b04682  1
2016 Butz H, Nofech-Mozes R, Ding Q, Khella HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, Krylov S, Yousef GM. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma European Urology Focus. 2: 210-218. DOI: 10.1016/j.euf.2015.11.006  1
2016 Rotondo F, Butz H, Syro LV, Yousef GM, Di Ieva A, Restrepo LM, Quintanar-Stephano A, Berczi I, Kovacs K. Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system Pituitary. 1-11. DOI: 10.1007/s11102-015-0703-0  1
2015 Gabril M, Girgis H, Scorilas A, Rotondo F, Wala S, Bjarnason GA, Ding Q, Evans A, Tawedrous E, Pasic M, Finelli A, Al-Haddad S, Yousef GM. S100A11 is a potential prognostic marker for clear cell renal cell carcinoma. Clinical & Experimental Metastasis. PMID 26472670 DOI: 10.1007/s10585-015-9758-6  1
2015 Luchini C, Veronese N, Solmi M, Cho H, Kim JH, Chou A, Gill AJ, Faraj SF, Chaux A, Netto GJ, Nakayama K, Kyo S, Lee SY, Kim DW, Yousef GM, et al. Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. Oncotarget. PMID 26384299 DOI: 10.18632/oncotarget.5142  1
2015 Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM. Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26224476 DOI: 10.1007/s13277-015-3802-7  1
2015 Khella HW, Butz H, Ding Q, Rotondo F, Evans KR, Kupchak P, Dharsee M, Latif A, Pasic MD, Lianidou E, Bjarnason GA, Yousef GM. miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26201448 DOI: 10.1038/mt.2015.129  1
2015 Yousef GM. Personalized Medicine in Kidney Cancer: Learning How to Walk Before We Run. European Urology. 68: 1021-2. PMID 26166627 DOI: 10.1016/j.eururo.2015.06.037  1
2015 Wala SJ, Karamchandani JR, Saleeb R, Evans A, Ding Q, Ibrahim R, Jewett M, Pasic M, Finelli A, Pace K, Lianidou E, Yousef GM. An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathways. Molecular Oncology. PMID 26051997 DOI: 10.1016/j.molonc.2015.04.007  1
2015 White-Al Habeeb NM, Di Meo A, Scorilas A, Rotondo F, Masui O, Seivwright A, Gabril M, Girgis AH, Jewett MA, Yousef GM. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma. Clinical & Experimental Metastasis. 32: 531-41. PMID 26037892 DOI: 10.1007/s10585-015-9725-2  1
2015 Lichner Z, Ding Q, Samaan S, Saleh C, Nasser A, Al-Haddad S, Samuel JN, Fleshner NE, Stephan C, Jung K, Yousef GM. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways. The Journal of Pathology. PMID 26011734 DOI: 10.1002/path.4568  1
2015 Saleeb R, Faragalla H, Yousef GM, Stewart R, Streutker CJ. Malignancies arising in allograft kidneys, with a first reported translocation RCC post-transplantation: A case series. Pathology, Research and Practice. 211: 584-7. PMID 26008778 DOI: 10.1016/j.prp.2015.04.009  1
2015 Butz H, Szabó PM, Khella HW, Nofech-Mozes R, Patocs A, Yousef GM. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1. Oncotarget. 6: 12543-57. PMID 26002553 DOI: 10.18632/oncotarget.3815  1
2015 Yousef GM. miRSNP-Based Approach Identifies a miRNA That Regulates Prostate-Specific Antigen in an Allele-Specific Manner. Cancer Discovery. 5: 351-2. PMID 25847955 DOI: 10.1158/2159-8290.CD-15-0230  1
2015 Papadopoulos EI, Yousef GM, Scorilas A. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 3197-207. PMID 25833690 DOI: 10.1007/s13277-014-2190-8  1
2015 Papadopoulos EI, Yousef GM, Scorilas A. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 70: 33-40. PMID 25776476 DOI: 10.1016/j.biopha.2014.12.043  1
2015 Pasic MD, Sotiropoulou G, Yousef GM. The miRNA-Kallikrein interactions: adding a new dimension. Cell Cycle (Georgetown, Tex.). 14: 691-2. PMID 25714545 DOI: 10.1080/15384101.2015.1006541  1
2015 Karamchandani JR, Gabril MY, Ibrahim R, Scorilas A, Filter E, Finelli A, Lee JY, Ordon M, Pasic M, Romaschin AD, Yousef GM. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma. Human Pathology. 46: 673-80. PMID 25704627 DOI: 10.1016/j.humpath.2014.11.007  1
2015 Grin A, Samaan S, Tripathi M, Rotondo F, Kovacs K, Bassily MN, Yousef GM. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma. Human Pathology. 46: 541-8. PMID 25649006 DOI: 10.1016/j.humpath.2014.12.005  1
2015 Khella HW, Scorilas A, Mozes R, Mirham L, Lianidou E, Krylov SN, Lee JY, Ordon M, Stewart R, Jewett MA, Yousef GM. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma. The American Journal of Pathology. 185: 693-703. PMID 25572155 DOI: 10.1016/j.ajpath.2014.11.017  1
2015 Samaan S, Khella HW, Girgis A, Scorilas A, Lianidou E, Gabril M, Krylov SN, Jewett M, Bjarnason GA, El-said H, Yousef GM. miR-210 is a prognostic marker in clear cell renal cell carcinoma. The Journal of Molecular Diagnostics : Jmd. 17: 136-44. PMID 25555365 DOI: 10.1016/j.jmoldx.2014.10.005  1
2015 Rotondo F, Di Ieva A, Kovacs K, Cusimano MD, Syro LV, Diamandis EP, Yousef GM. Human kallikrein 10 in surgically removed human pituitary adenomas. Hormones (Athens, Greece). 14: 272-9. PMID 25553760 DOI: 10.14310/horm.2002.1558  1
2015 Di Meo A, Rotondo F, Kovacs K, Cusimano MD, Syro LV, Di Ieva A, Diamandis EP, Yousef GM. Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 23: 433-7. PMID 25517869 DOI: 10.1097/PAI.0000000000000108  1
2015 Wegman DW, Ghasemi F, Khorshidi A, Yang BB, Liu SK, Yousef GM, Krylov SN. Highly-sensitive amplification-free analysis of multiple miRNAs by capillary electrophoresis. Analytical Chemistry. 87: 1404-10. PMID 25495883 DOI: 10.1021/ac504406s  1
2015 Iakovleva G, Iakovlev V, Ordon M, Srigley J, Yousef GM. Tubulocystic carcinoma of kidney: a challenging diagnostic entity mimicking multicystic kidney and presenting with bone metastasis. Histopathology. 66: 892-4. PMID 25109328 DOI: 10.1111/his.12502  1
2015 Lichner Z, Saleh C, Subramaniam V, Seivwright A, Prud'homme GJ, Yousef GM. miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/tumor initiating cell properties Oncotarget. 6: 5567-5581.  1
2014 Mekhail SM, Yousef PG, Jackinsky SW, Pasic M, Yousef GM. miRNA in Prostate Cancer: New Prospects for Old Challenges. Ejifcc. 25: 79-98. PMID 27683458  0.4
2014 Sidiropoulos KG, White NM, Bui A, Ding Q, Boulos P, Pampalakis G, Khella H, Samuel JN, Sotiropoulou G, Yousef GM. Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer. Oncoscience. 1: 709-24. PMID 25593998  0.48
2014 Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer. Biological Chemistry. 395: 1087-93. PMID 25153389 DOI: 10.1515/hsz-2014-0143  1
2014 Samaan S, Lichner Z, Ding Q, Saleh C, Samuel J, Streutker C, Yousef GM. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression. Biological Chemistry. 395: 991-1001. PMID 25153383 DOI: 10.1515/hsz-2013-0288  1
2014 Yousef GM, Pasic M, Diamandis EP. Highlight: the 5th International Symposium on Kallikreins and Kallikrein-Related Peptidases. Biological Chemistry. 395: 913-4. PMID 25153379 DOI: 10.1515/hsz-2014-0228  1
2014 Butz H, Szabó PM, Nofech-Mozes R, Rotondo F, Kovacs K, Mirham L, Girgis H, Boles D, Patocs A, Yousef GM. Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma. Clinical Chemistry. 60: 1314-26. PMID 25139457 DOI: 10.1373/clinchem.2014.225854  1
2014 Girgis H, Masui O, White NM, Scorilas A, Rotondo F, Seivwright A, Gabril M, Filter ER, Girgis AH, Bjarnason GA, Jewett MA, Evans A, Al-Haddad S, Siu KM, Yousef GM. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Molecular Cancer. 13: 101. PMID 24885701 DOI: 10.1186/1476-4598-13-101  1
2014 Di Ieva A, Butz H, Niamah M, Rotondo F, De Rosa S, Sav A, Yousef GM, Kovacs K, Cusimano MD. MicroRNAs as biomarkers in pituitary tumors. Neurosurgery. 75: 181-9; discussion 18. PMID 24739366 DOI: 10.1227/NEU.0000000000000369  1
2014 White NM, Masui O, Desouza LV, Krakovska O, Metias S, Romaschin AD, Honey RJ, Stewart R, Pace K, Lee J, Jewett MA, Bjarnason GA, Siu KW, Yousef GM. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget. 5: 506-18. PMID 24504108  1
2014 White NM, Masui O, Newsted D, Scorilas A, Romaschin AD, Bjarnason GA, Siu KW, Yousef GM. Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis. British Journal of Cancer. 110: 1250-9. PMID 24496460 DOI: 10.1038/bjc.2013.828  1
2014 White NM, Newsted DW, Masui O, Romaschin AD, Siu KW, Yousef GM. Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 1833-46. PMID 24136743 DOI: 10.1007/s13277-013-1245-6  1
2014 Markou A, Yousef GM, Stathopoulos E, Georgoulias V, Lianidou E. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. Clinical Chemistry. 60: 197-205. PMID 24132943 DOI: 10.1373/clinchem.2013.210542  1
2014 Sidiropoulos KG, White NMA, Bui A, Ding Q, Boulos P, Pampalakis G, Khella H, Samuel JN, Sotiropoulou G, Yousef GM. Kallikrein-related peptidase 5 induces miRNA-mediated antioncogenic pathways in breast cancer Oncoscience. 1: 709-724. DOI: 10.18632/oncoscience.91  1
2014 Pasic M, Hojilla C, Yousef GM. Polymerase chain reaction Molecular Testing in Cancer. 2147483647: 39-54. DOI: 10.1007/978-1-4899-8050-2_4  1
2014 Gabril MY, Yousef GM. Molecular testing in urothelial tumors Molecular Testing in Cancer. 2147483647: 301-317. DOI: 10.1007/978-1-4899-8050-2_18  1
2014 Gabril MY, Yousef GM. Molecular testing in prostate cancer Molecular Testing in Cancer. 2147483647: 277-300. DOI: 10.1007/978-1-4899-8050-2_17  1
2014 Gabril MY, Yousef GM. Molecular testing in adult kidney tumors Molecular Testing in Cancer. 2147483647: 257-275. DOI: 10.1007/978-1-4899-8050-2_16  1
2014 Yousef GM, Jothy S. Molecular testing in cancer Molecular Testing in Cancer. 2147483647: 1-442. DOI: 10.1007/978-1-4899-8050-2  1
2013 Schaefer A, Saleh C, Nasser A, Boles D, Al-Haddad S, Kupchak P, Dharsee M, Nuin PS, Evans KR, Jung K, Stephan C, Fleshner NE, Yousef GM. Use of microRNA signature to distinguish early from late biochemical failure in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 194. PMID 28137175 DOI: 10.1200/jco.2013.31.6_suppl.194  0.6
2013 Schmitt M, Magdolen V, Yang F, Kiechle M, Bayani J, Yousef GM, Scorilas A, Diamandis EP, Dorn J. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies. Radiology and Oncology. 47: 319-29. PMID 24294176 DOI: 10.2478/raon-2013-0053  1
2013 Fendler A, Jung M, Stephan C, Erbersdobler A, Jung K, Yousef GM. The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1. Plos One. 8: e80807. PMID 24260486 DOI: 10.1371/journal.pone.0080807  1
2013 Ghasemi F, Wegman DW, Kanoatov M, Yang BB, Liu SK, Yousef GM, Krylov SN. Improvements to direct quantitative analysis of multiple microRNAs facilitating faster analysis. Analytical Chemistry. 85: 10062-6. PMID 24127917 DOI: 10.1021/ac402812f  1
2013 Lichner Z, Fendler A, Saleh C, Nasser AN, Boles D, Al-Haddad S, Kupchak P, Dharsee M, Nuin PS, Evans KR, Jung K, Stephan C, Fleshner NE, Yousef GM. MicroRNA signature helps distinguish early from late biochemical failure in prostate cancer. Clinical Chemistry. 59: 1595-603. PMID 23958847 DOI: 10.1373/clinchem.2013.205450  1
2013 Kurban G, Gedye C, Morales C, Yousef GM, Almatar A, Jewett MA. Diagnosis and treatment of small renal masses: the role for molecular biology. Archivos EspañOles De UrologíA. 66: 505-16. PMID 23793768  1
2013 Dorn J, Bayani J, Yousef GM, Yang F, Magdolen V, Kiechle M, Diamandis EP, Schmitt M. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thrombosis and Haemostasis. 110: 408-22. PMID 23765253 DOI: 10.1160/TH13-03-0206  1
2013 Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 81: 388-96. PMID 23756108 DOI: 10.1016/j.lungcan.2013.05.007  1
2013 Wegman DW, Cherney LT, Yousef GM, Krylov SN. Universal drag tag for direct quantitative analysis of multiple microRNAs. Analytical Chemistry. 85: 6518-23. PMID 23742626 DOI: 10.1021/ac401185g  1
2013 Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA, Yousef GM. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis. 34: 2231-9. PMID 23715501 DOI: 10.1093/carcin/bgt184  1
2013 Pasic MD, Yousef GM, Diamandis EP. The proteomic revolution in laboratory medicine. Clinical Biochemistry. 46: 397-8. PMID 23497914 DOI: 10.1016/j.clinbiochem.2013.02.012  1
2013 Lichner Z, Scorilas A, White NM, Girgis AH, Rotstein L, Wiegand KC, Latif A, Chow C, Huntsman D, Yousef GM. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma. The American Journal of Pathology. 182: 1163-70. PMID 23416164 DOI: 10.1016/j.ajpath.2013.01.007  1
2013 Pasic MD, Samaan S, Yousef GM. Genomic medicine: new frontiers and new challenges. Clinical Chemistry. 59: 158-67. PMID 23284016 DOI: 10.1373/clinchem.2012.184622  1
2013 Khella HW, Bakhet M, Lichner Z, Romaschin AD, Jewett MA, Yousef GM. MicroRNAs in kidney disease: an emerging understanding. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 798-808. PMID 23219107 DOI: 10.1053/j.ajkd.2012.09.018  1
2013 Masui O, White NM, DeSouza LV, Krakovska O, Matta A, Metias S, Khalil B, Romaschin AD, Honey RJ, Stewart R, Pace K, Bjarnason GA, Siu KW, Yousef GM. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance. Molecular & Cellular Proteomics : McP. 12: 132-44. PMID 23082029 DOI: 10.1074/mcp.M112.020701  1
2013 Yousef GM, White NMA, Girgis AH. Kidney cancer genomics: Paving the road to a new paradigm of personalized medicine Cancer Genomics: Molecular Classification, Prognosis and Response Prediction. 2147483647: 185-217. DOI: 10.1007/978-94-007-5842-1_7  1
2012 Girgis AH, Iakovlev VV, Beheshti B, Bayani J, Squire JA, Bui A, Mankaruos M, Youssef Y, Khalil B, Khella H, Pasic M, Yousef GM. Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma. Cancer Research. 72: 5273-84. PMID 22926558 DOI: 10.1158/0008-5472.CAN-12-0656  1
2012 Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A, Lichner Z, Bjarnason G, Sugar L, Attalah MI, Yousef GM. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. The Journal of Molecular Diagnostics : Jmd. 14: 385-92. PMID 22580180 DOI: 10.1016/j.jmoldx.2012.02.003  1
2012 White NM, Youssef YM, Fendler A, Stephan C, Jung K, Yousef GM. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer. Biological Chemistry. 393: 379-89. PMID 22505520 DOI: 10.1515/hsz-2011-0246  1
2012 Pasic MD, Olkhov E, Bapat B, Yousef GM. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. Biological Chemistry. 393: 319-30. PMID 22505515 DOI: 10.1515/hsz-2011-0273  1
2012 Petraki C, Youssef YM, Dubinski W, Lichner Z, Scorilas A, Pasic MD, Komborozos V, Khalil B, Streutker C, Diamandis EP, Yousef GM. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 33: 1209-14. PMID 22437349 DOI: 10.1007/s13277-012-0368-5  1
2012 Girgis AH, Bui A, White NM, Yousef GM. Integrated genomic characterization of the kallikrein gene locus in cancer. Anticancer Research. 32: 957-63. PMID 22399617  1
2012 Lichner Z, Mejia-Guerrero S, Ignacak M, Krizova A, Bao TT, Girgis AH, Youssef YM, Yousef GM. Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. The American Journal of Pathology. 180: 1675-87. PMID 22326755 DOI: 10.1016/j.ajpath.2011.12.030  1
2012 Yousef GM. Personalized cancer genomics: the road map to clinical implementation. Clinical Chemistry. 58: 661-3. PMID 22322979 DOI: 10.1373/clinchem.2011.181073  1
2012 Petraki C, Dubinski W, Scorilas A, Saleh C, Pasic MD, Komborozos V, Khalil B, Gabril MY, Streutker C, Diamandis EP, Yousef GM. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Pathology, Research and Practice. 208: 104-8. PMID 22285222 DOI: 10.1016/j.prp.2011.12.010  1
2012 Dubinski W, Gabril M, Iakovlev VV, Scorilas A, Youssef YM, Faragalla H, Kovacs K, Rotondo F, Metias S, Arsanious A, Plotkin A, Girgis AH, Streutker CJ, Yousef GM. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis. Human Pathology. 43: 1037-43. PMID 22204709 DOI: 10.1016/j.humpath.2011.08.012  1
2012 Khella HW, White NM, Faragalla H, Gabril M, Boazak M, Dorian D, Khalil B, Antonios H, Bao TT, Pasic MD, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, ... Yousef GM, et al. Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 33: 131-40. PMID 22086373 DOI: 10.1007/s13277-011-0255-5  1
2012 Iakovlev VV, Gabril M, Dubinski W, Scorilas A, Youssef YM, Faragalla H, Kovacs K, Rotondo F, Metias S, Arsanious A, Plotkin A, Girgis AH, Streutker CJ, Yousef GM. Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 46-56. PMID 22042086 DOI: 10.1038/labinvest.2011.153  1
2011 White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. British Journal of Cancer. 105: 1741-9. PMID 22033272 DOI: 10.1038/bjc.2011.401  1
2011 White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Yousef GM. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. The Journal of Urology. 186: 1077-83. PMID 21784468 DOI: 10.1016/j.juro.2011.04.110  1
2011 Fendler A, Jung M, Stephan C, Honey RJ, Stewart RJ, Pace KT, Erbersdobler A, Samaan S, Jung K, Yousef GM. miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression. International Journal of Oncology. 39: 1183-92. PMID 21769427 DOI: 10.3892/ijo.2011.1128  1
2011 Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, Syro LV, Kovacs K, Lloyd RV. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Research. 31: 2283-90. PMID 21737653  1
2011 Fendler A, Stephan C, Yousef GM, Jung K. MicroRNAs as regulators of signal transduction in urological tumors. Clinical Chemistry. 57: 954-68. PMID 21632885 DOI: 10.1373/clinchem.2010.157727  1
2011 White NM, Yousef GM. Translating molecular signatures of renal cell carcinoma into clinical practice. The Journal of Urology. 186: 9-11. PMID 21571339 DOI: 10.1016/j.juro.2011.04.003  1
2011 Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, Evans A, Yousef GM. Accurate molecular classification of kidney cancer subtypes using microRNA signature. European Urology. 59: 721-30. PMID 21272993 DOI: 10.1016/j.eururo.2011.01.004  1
2011 Faragalla HF, Marcon NE, Yousef GM, Streutker CJ. Immunohistochemical staining for smoothelin in the duplicated versus the true muscularis mucosae of Barrett esophagus. The American Journal of Surgical Pathology. 35: 55-9. PMID 21164287 DOI: 10.1097/PAS.0b013e3182035fb6  1
2011 White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: a stepping stone towards improved cancer management. Nature Reviews. Clinical Oncology. 8: 75-84. PMID 21045789 DOI: 10.1038/nrclinonc.2010.173  1
2010 White NM, Yousef GM. MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. Bmc Medicine. 8: 65. PMID 20964839 DOI: 10.1186/1741-7015-8-65  1
2010 Rotondo F, Sharma S, Scheithauer BW, Horvath E, Syro LV, Cusimano M, Nassiri F, Yousef GM, Kovacs K. Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes. Neoplasma. 57: 590-3. PMID 20845998 DOI: 10.4149/neo_2010_06_591  1
2010 Diamandis M, White NM, Yousef GM. Personalized medicine: marking a new epoch in cancer patient management. Molecular Cancer Research : McR. 8: 1175-87. PMID 20693306 DOI: 10.1158/1541-7786.MCR-10-0264  1
2010 Faragalla H, Al-Haddad S, Stewart R, Yousef GM. The significance of florid giant cell component in renal cell carcinoma: a case report and review of the literature. The Canadian Journal of Urology. 17: 5219-22. PMID 20566020  1
2010 Schaefer A, Stephan C, Busch J, Yousef GM, Jung K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nature Reviews. Urology. 7: 286-97. PMID 20368743 DOI: 10.1038/nrurol.2010.45  1
2010 White NMA, Chow TFF, Mejia-Guerrero S, Diamandis M, Rofael Y, Faragalla H, Mankaruous M, Gabril M, Girgis A, Yousef GM. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer British Journal of Cancer. 102: 1244-1253. PMID 20354523 DOI: 10.1038/sj.bjc.6605634  1
2010 White NM, Bui A, Mejia-Guerrero S, Chao J, Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace KT, Sugar L, Diamandis EP, Doré J, Yousef GM. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biological Chemistry. 391: 411-23. PMID 20180642 DOI: 10.1515/BC.2010.041  1
2010 Gabril M, White NM, Moussa M, Chow TF, Metias SM, Fatoohi E, Yousef GM. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications. Biological Chemistry. 391: 403-9. PMID 20128686 DOI: 10.1515/BC.2010.025  1
2010 Gabril MY, Yousef GM. Informatics for practicing anatomical pathologists: marking a new era in pathology practice. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 23: 349-58. PMID 20081805 DOI: 10.1038/modpathol.2009.190  1
2010 Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, Pace KT, Yousef GM. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. The Journal of Urology. 183: 743-51. PMID 20022054 DOI: 10.1016/j.juro.2009.09.086  1
2010 Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clinical Biochemistry. 43: 150-8. PMID 19646430 DOI: 10.1016/j.clinbiochem.2009.07.020  1
2009 White NM, Mathews M, Yousef GM, Prizada A, Fontaine D, Ghatage P, Popadiuk C, Dawson L, Doré JJ. Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone. Cancer Biomarkers : Section a of Disease Markers. 5: 279-87. PMID 20037204 DOI: 10.3233/CBM-2009-0113  1
2009 Yousef GM, Diamandis EP. The human kallikrein gene family: new biomarkers for ovarian cancer. Cancer Treatment and Research. 149: 165-87. PMID 19763436 DOI: 10.1007/978-0-387-98094-2_8  1
2009 Metias SM, Lianidou E, Yousef GM. MicroRNAs in clinical oncology: At the crossroads between promises and problems Journal of Clinical Pathology. 62: 771-776. PMID 19734473 DOI: 10.1136/jcp.2009.064717  1
2009 White NM, Mathews M, Yousef GM, Prizada A, Popadiuk C, Doré JJ. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. British Journal of Cancer. 101: 1107-13. PMID 19707197 DOI: 10.1038/sj.bjc.6605280  1
2009 Hamodat M, Naghibi B, Yousef GM. Malakoplakia of the neck in a patient with cancer of the colon. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 52: E107-E108. PMID 19680495  1
2009 Angelopoulou K, Prassas I, Yousef GM. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer. Gene. 446: 68-74. PMID 19619623 DOI: 10.1016/j.gene.2009.07.007  1
2009 Siu KW, DeSouza LV, Scorilas A, Romaschin AD, Honey RJ, Stewart R, Pace K, Youssef Y, Chow TF, Yousef GM. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. Journal of Proteome Research. 8: 3797-807. PMID 19610612 DOI: 10.1021/pr800389e  1
2009 Yousef GM. Notice of retraction: omission of author in "Malakoplakia outside the urinary tract" (Arch Pathol Lab Med. 2007;131(2):297-300). Archives of Pathology & Laboratory Medicine. 133: 850. PMID 19492874 DOI: 10.1043/1543-2165-133.6.850.b  1
2009 Arsanious A, Bjarnason GA, Yousef GM. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Molecular Cancer. 8: 20. PMID 19291329 DOI: 10.1186/1476-4598-8-20  1
2009 Romaschin AD, Youssef Y, Chow TF, Siu KW, DeSouza LV, Honey RJ, Stewart R, Pace KT, Yousef GM. Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins. Biological Chemistry. 390: 125-35. PMID 19090715 DOI: 10.1515/BC.2009.013  1
2009 Yousef GM, Naghibi B, Hamodat MM. Malakoplakia outside the urinary tract (Archives of Pathology and Laboratory Medicine (2007) 131, 2, (297-300)) Archives of Pathology and Laboratory Medicine. 133: 850.  1
2008 Yousef GM. microRNAs: a new frontier in kallikrein research. Biological Chemistry. 389: 689-94. PMID 18627305 DOI: 10.1515/BC.2008.068  1
2008 Chow TF, Crow M, Earle T, El-Said H, Diamandis EP, Yousef GM. Kallikreins as microRNA targets: an in silico and experimental-based analysis. Biological Chemistry. 389: 731-8. PMID 18627289 DOI: 10.1515/BC.2008.071  1
2008 White NM, Gabril M, Ejeckam G, Mathews M, Fardy J, Kamel F, Doré J, Yousef GM. Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 22: 369-75. PMID 18414711  1
2007 Yousef GM, Denic N, Wadhwa J, Chandracanth SA, Smith T, Elms F, Diamandis EP. Intravagal ectopic parathyroid presenting as vocal cord paralysis: case report and review of the literature. The Journal of Otolaryngology. 36: E93-5. PMID 18076837  1
2007 Gabril MY, Yousef GM. Salivary duct carcinoma presenting with vaginal metastasis: Case report European Journal of Gynaecological Oncology. 28: 415-417. PMID 17966226  1
2007 Barron J, Morris-Larkin C, Finch T, Maroun F, Hache N, Yousef GM. Long survival of primary pineal melanoma with radiation treatment only. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 34: 251-3. PMID 17598609  1
2007 Yousef GM, Naghibi B, Hamodat MM. Malakoplakia outside the urinary tract. Archives of Pathology & Laboratory Medicine. 131: 297-300. PMID 17284117 DOI: 10.1043/1543-2165(2007)131[297:MOTUT]2.0.CO;2  1
2007 Yousef GM, Naghibi B. In reply [5] Archives of Pathology and Laboratory Medicine. 131: 1512-1513.  1
2006 Lundwall A, Band V, Blaber M, Clements JA, Courty Y, Diamandis EP, Fritz H, Lilja H, Malm J, Maltais LJ, Olsson AY, Petraki C, Scorilas A, Sotiropoulou G, Stenman UH, ... ... Yousef GM, et al. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biological Chemistry. 387: 637-41. PMID 16800724 DOI: 10.1515/BC.2006.082  1
2006 Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association. 13: 238-43. PMID 16643616 DOI: 10.1111/j.1442-2042.2006.01276.x  1
2006 Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 27: 1-7. PMID 16340244 DOI: 10.1159/000090150  1
2005 Yousef GM, Ejeckam GC, Best LM, Diamandis EP. Collecting duct carcinoma associated with oncocytoma. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 31: 465-7; discussion 46. PMID 16255793  1
2005 Stephan C, Jung K, Soosaipillai A, Yousef GM, Cammann H, Meyer H, Xu C, Diamandis EP. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection. Bju International. 96: 521-7. PMID 16104903 DOI: 10.1111/j.1464-410X.2005.05677.x  1
2005 Yousef GM, White NM, Michael IP, Cho JC, Robb JD, Kurlender L, Khan S, Diamandis EP. Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 26: 227-35. PMID 16103744 DOI: 10.1159/000087377  1
2005 Yousef GM, Obiezu CV, Luo LY, Magklara A, Borgoño CA, Kishi T, Memari N, Michael lP, Sidiropoulos M, Kurlender L, Economopolou K, Kapadia C, Komatsu N, Petraki C, Elliott M, et al. Human tissue kallikreins: from gene structure to function and clinical applications. Advances in Clinical Chemistry. 39: 11-79. PMID 16013667 DOI: 10.1016/S0065-2423(04)39002-5  1
2005 Kurlender L, Borgono C, Michael IP, Obiezu C, Elliott MB, Yousef GM, Diamandis EP. A survey of alternative transcripts of human tissue kallikrein genes. Biochimica Et Biophysica Acta. 1755: 1-14. PMID 15878240 DOI: 10.1016/j.bbcan.2005.02.001  1
2005 Michael IP, Kurlender L, Memari N, Yousef GM, Du D, Grass L, Stephan C, Jung K, Diamandis EP. Intron retention: a common splicing event within the human kallikrein gene family. Clinical Chemistry. 51: 506-15. PMID 15650036 DOI: 10.1373/clinchem.2004.042341  1
2004 Yousef GM, Borgoño CA, White NM, Robb JD, Michael IP, Oikonomopoulou K, Khan S, Diamandis EP. In silico analysis of the human kallikrein gene 6. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 282-9. PMID 15627893 DOI: 10.1159/000081393  1
2004 Yousef GM, White NM, Kurlender L, Michael I, Memari N, Robb JD, Katsaros D, Stephan C, Jung K, Diamandis EP. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 221-7. PMID 15627884 DOI: 10.1159/000081384  1
2004 Yousef GM, Borgono CA, Michael IP, Diamandis EP. Cloning of a kallikrein pseudogene. Clinical Biochemistry. 37: 961-7. PMID 15498522 DOI: 10.1016/j.clinbiochem.2004.07.012  1
2004 Kurlender L, Yousef GM, Memari N, Robb JD, Michael IP, Borgoño C, Katsaros D, Stephan C, Jung K, Diamandis EP. Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 149-56. PMID 15361712 DOI: 10.1159/000079147  1
2004 Yousef GM, Borgoño CA, Michael IP, Davidian C, Stephan C, Jung K, Diamandis EP. Molecular cloning of a new gene which is differentially expressed in breast and prostate cancers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 122-33. PMID 15361709 DOI: 10.1159/000079144  1
2004 Yousef GM, Elliott MB, Kopolovic AD, Serry E, Diamandis EP. Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochimica Et Biophysica Acta. 1698: 77-86. PMID 15063317 DOI: 10.1016/j.bbapap.2003.10.008  1
2004 Yousef GM, Borgoño CA, Popalis C, Yacoub GM, Polymeris ME, Soosaipillai A, Diamandis EP. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers. Anticancer Research. 24: 43-51. PMID 15015574  1
2004 Diamandis EP, Yousef GM, Olsson AY. An update on human and mouse glandular kallikreins. Clinical Biochemistry. 37: 258-60. PMID 15003726 DOI: 10.1016/j.clinbiochem.2003.12.013  1
2004 Yousef GM, Yacoub GM, Polymeris ME, Popalis C, Soosaipillai A, Diamandis EP. Kallikrein gene downregulation in breast cancer British Journal of Cancer. 90: 167-172. PMID 14710225 DOI: 10.1038/sj.bjc.6601451  1
2004 Kapadia C, Yousef GM, Mellati AA, Magklara A, Wasney GA, Diamandis EP. Complex formation between human kallikrein 13 and serum protease inhibitors. Clinica Chimica Acta; International Journal of Clinical Chemistry. 339: 157-67. PMID 14687906 DOI: 10.1016/j.cccn.2003.10.009  1
2004 Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Kishi T, Nakamura T, Loening SA, Diamandis EP. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. The Journal of Urology. 171: 187-91. PMID 14665873 DOI: 10.1097/01.ju.0000101622.74236.94  1
2003 Diamandis EP, Borgoño CA, Scorilas A, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 24: 299-309. PMID 15004490 DOI: 10.1159/000076462  1
2003 Borgoño CA, Grass L, Soosaipillai A, Yousef GM, Petraki CD, Howarth DH, Fracchioli S, Katsaros D, Diamandis EP. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Cancer Research. 63: 9032-41. PMID 14695222  1
2003 Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clinical Biochemistry. 36: 443-52. PMID 12951170 DOI: 10.1016/S0009-9120(03)00055-9  1
2003 Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault de la Longrais IA, Puopolo M, Massobrio M, Diamandis EP. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3119-26. PMID 12915603 DOI: 10.1200/JCO.2003.09.111  1
2003 Yousef GM, Kapadia C, Polymeris ME, Borgono C, Hutchinson S, Wasney GA, Soosaipillai A, Diamandis EP. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids. Biochimica Et Biophysica Acta. 1628: 88-96. PMID 12890555 DOI: 10.1016/S0167-4781(03)00116-7  1
2003 Yousef GM, Diamandis EP. Tissue kallikreins: new players in normal and abnormal cell growth? Thrombosis and Haemostasis. 90: 7-16. PMID 12876620 DOI: 10.1267/THRO03010007  1
2003 Yousef GM, Polymeris ME, Grass L, Soosaipillai A, Chan PC, Scorilas A, Borgoño C, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Diamandis EP. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Research. 63: 3958-65. PMID 12873991  1
2003 Yousef GM, Stephan C, Scorilas A, Ellatif MA, Jung K, Kristiansen G, Jung M, Polymeris ME, Diamandis EP. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. The Prostate. 56: 287-92. PMID 12858357 DOI: 10.1002/pros.10263  1
2003 Borgoño CA, Fracchioli S, Yousef GM, Rigault de la Longrais IA, Luo LY, Soosaipillai A, Puopolo M, Grass L, Scorilas A, Diamandis EP, Katsaros D. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. International Journal of Cancer. Journal International Du Cancer. 106: 605-10. PMID 12845660 DOI: 10.1002/ijc.11296  1
2003 Scorilas A, Chiang PM, Katsaros D, Yousef GM, Diamandis EP. Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors. Gene. 310: 79-89. PMID 12801635 DOI: 10.1016/S0378-1119(03)00499-2  1
2003 Nakamura T, Stephan C, Scorilas A, Yousef GM, Jung K, Diamandis EP. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. Urology. 61: 1042-6. PMID 12736044 DOI: 10.1016/S0090-4295(02)02443-3  1
2003 Yousef GM, Kopolovic AD, Elliott MB, Diamandis EP. Genomic overview of serine proteases. Biochemical and Biophysical Research Communications. 305: 28-36. PMID 12732192 DOI: 10.1016/S0006-291X(03)00638-7  1
2003 Yousef GM, Polymeris ME, Yacoub GM, Scorilas A, Soosaipillai A, Popalis C, Fracchioli S, Katsaros D, Diamandis EP. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Research. 63: 2223-7. PMID 12727843  1
2003 Yousef GM, Scorilas A, Nakamura T, Ellatif MA, Ponzone R, Biglia N, Maggiorotto F, Roagna R, Sismondi P, Diamandis EP. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Research and Treatment. 78: 149-58. PMID 12725415 DOI: 10.1023/A:1022931403825  1
2003 Hutchinson S, Luo LY, Yousef GM, Soosaipillai A, Diamandis EP. Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin. Clinical Chemistry. 49: 746-51. PMID 12709365 DOI: 10.1373/49.5.746  1
2003 Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G, Jung K, Diamandis EP. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues British Journal of Cancer. 88: 1101-1104. PMID 12671711 DOI: 10.1038/sj.bjc.6600869  1
2003 Yousef GM, Fracchioli S, Scorilas A, Borgoño CA, Iskander L, Puopolo M, Massobrio M, Diamandis EP, Katsaros D. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer. American Journal of Clinical Pathology. 119: 346-55. PMID 12645335  1
2003 Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AGJ, Vergote I, Katsaros D. Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma Journal of Clinical Oncology. 21: 1035-1043. PMID 12637468 DOI: 10.1200/JCO.2003.02.022  1
2003 Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer Clinical Biochemistry. 36: 135-143. PMID 12633763 DOI: 10.1016/S0009-9120(02)00446-0  1
2003 Yousef GM, Kishi T, Diamandis EP. Role of kallikrein enzymes in the central nervous system Clinica Chimica Acta. 329: 1-8. PMID 12589961 DOI: 10.1016/S0009-8981(03)00004-4  1
2003 Kapadia C, Chang A, Sotiropoulou G, Yousef GM, Grass L, Soosaipillai A, Xing X, Howarth DHC, Diamandis EP. Human kallikrein 13: Production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay Clinical Chemistry. 49: 77-86. PMID 12507963 DOI: 10.1373/49.1.77  1
2003 Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Bharaj BS, Nakamura T, Loening SA, Diamandis EP. Quantitative analysis of kallikrein 15 gene expression in prostate tissue Journal of Urology. 169: 361-364. PMID 12478190  1
2003 Yousef GM, Diamandis EP. Human kallikreins: Common structural features, sequence analysis and evolution Current Genomics. 4: 147-165. DOI: 10.2174/1389202033350074  1
2002 Yousef GM, Scorilas A, Magklara A, Memari N, Ponzone R, Sismondi P, Biglia N, Abd Ellatif M, Diamandis EP. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer British Journal of Cancer. 87: 1294-1300. PMID 12439720 DOI: 10.1038/sj.bjc.6600590  1
2002 Yousef GM, Borgoño CA, Scorilas A, Ponzone R, Biglia N, Iskander L, Polymeris ME, Roagna R, Sismondi P, Diamandis EP. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis British Journal of Cancer. 87: 1287-1293. PMID 12439719 DOI: 10.1038/sj.bjc.6600623  1
2002 Yousef GM, Diamandis EP. Human tissue kallikreins: A new enzymatic cascade pathway? Biological Chemistry. 383: 1045-1057. PMID 12437087 DOI: 10.1515/BC.2002.113  1
2002 Yousef GM, Obiezu CV, Jung K, Stephan C, Scorilas A, Diamandis EP. Differential expression of kallikrein gene 5 in cancerous and normal testicular tissues Urology. 60: 714-718. PMID 12385949 DOI: 10.1016/S0090-4295(02)01811-3  1
2002 Yousef GM, Diamandis EP. Expanded human tissue kallikrein family - A novel panel of cancer biomarkers Tumor Biology. 23: 185-192. PMID 12218299 DOI: 10.1159/000064027  1
2002 Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: An independent indicator of poor prognosis in breast cancer Clinical Chemistry. 48: 1241-1250. PMID 12142380  1
2002 Diamandis EP, Yousef GM. Human tissue kallikreins: A family of new cancer biomarkers Clinical Chemistry. 48: 1198-1205. PMID 12142373  1
2002 Mahmoud AAH, Yousef GM, Al-Hifzi I, Diamandis EP. Cockayne syndrome in three sisters with varying clinical presentation American Journal of Medical Genetics. 111: 81-85. PMID 12124741 DOI: 10.1002/ajmg.10492  1
2002 Yousef GM, Diamandis EP. Kallikreins, steroid hormones and ovarian cancer: is there a link? Minerva Endocrinologica. 27: 157-166. PMID 12091791  1
2002 Chang A, Yousef GM, Scorilas A, Grass L, Sismondi P, Ponzone R, Diamandis EP. Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: An independent indicator of favourable prognosis in breast cancer British Journal of Cancer. 86: 1457-1464. PMID 11986781 DOI: 10.1038/sj.bjc.6600283  1
2002 Yousef GM, Scorilas A, Chang A, Rendl L, Diamandis M, Jung K, Diamandis EP. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues Prostate. 51: 126-132. PMID 11948967 DOI: 10.1002/pros.10067  1
2002 Yousef GM, Ordon MH, Foussias G, Diamandis EP. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes Gene. 286: 259-270. PMID 11943481 DOI: 10.1016/S0378-1119(02)00432-8  1
2001 Diamandis EP, Yousef GM. Human tissue kallikrein gene family: A rich source of novel disease biomarkers Expert Review of Molecular Diagnostics. 1: 182-190. PMID 11901813  1
2001 Chang A, Yousef GM, Jung K, Rajpert-De Meyts E, Diamandis EP. Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: Differential expression in the human testis and testicular cancer Anticancer Research. 21: 3147-3152. PMID 11848466  1
2001 Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker Cancer Research. 61: 7811-7818. PMID 11691797  1
2001 Petraki CD, Karavana VN, Skoufogiannis PT, Little SP, Howarth DJC, Yousef GM, Diamandis EP. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry Journal of Histochemistry and Cytochemistry. 49: 1431-1441. PMID 11668196  1
2001 Shimizu-Okabe C, Yousef GM, Diamandis EP, Yoshida S, Shiosaka S, Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport. 12: 2747-51. PMID 11522960  1
2001 Obiezu CV, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Rigault de la Longrais IA, Arisio R, Diamandis EP. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients Clinical Cancer Research. 7: 2380-2386. PMID 11489816  1
2001 Yousef GM, Bharaj BS, Yu H, Poulopoulos J, Diamandis EP. Sequence analysis of the human kallikrein gene locus identifies a unique polymorphic minisatellite element. Biochemical and Biophysical Research Communications. 285: 1321-9. PMID 11478802 DOI: 10.1006/bbrc.2001.5321  1
2001 Scorilas A, Yousef GM, Jung K, Meyts ERD, Carsten S, Diamandis EP. Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors Biochemical and Biophysical Research Communications. 285: 400-408. PMID 11444856 DOI: 10.1006/bbrc.2001.5165  1
2001 Yousef GM, Ordon MH, Foussias G, Diamandis EP. Molecular characterization, tissue expression, and mapping of a novel siglec-like gene (SLG2) with three splice variants Biochemical and Biophysical Research Communications. 284: 900-910. PMID 11409878 DOI: 10.1006/bbrc.2001.5053  1
2001 Foussias G, Taylor SM, Yousef GM, Tropak MB, Ordon MH, Diamandis EP. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs Biochemical and Biophysical Research Communications. 284: 887-899. PMID 11409877 DOI: 10.1006/bbrc.2001.5052  1
2001 Scorilas A, Kyriakopoulou L, Yousef GM, Ashworth LK, Kwamie A, Diamandis EP. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family Genomics. 72: 217-221. PMID 11401436 DOI: 10.1006/geno.2000.6455  1
2001 Magklara A, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Danese S, Diamandis EP. The human KLK8 (neuropsin/ovasin) gene: Identification of two novel splice variants and its prognostic value in ovarian cancer Clinical Cancer Research. 7: 806-811. PMID 11309326  1
2001 Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies Cancer Research. 61: 3425-3431. PMID 11309303  1
2001 Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: Structure, function, and association to disease Endocrine Reviews. 22: 184-204. PMID 11294823 DOI: 10.1210/er.22.2.184  1
2001 Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer British Journal of Cancer. 84: 643-650. PMID 11237385 DOI: 10.1054/bjoc.2000.1649  1
2001 Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer Journal of Biological Chemistry. 276: 53-61. PMID 11010966 DOI: 10.1074/jbc.M005432200  1
2000 Diamandis EP, Yousef GM, Petraki C, Soosaipillai AR. Human kallikrein 6 as a biomarker of Alzheimer's disease Clinical Biochemistry. 33: 663-667. PMID 11166014 DOI: 10.1016/S0009-9120(00)00185-5  1
2000 Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P. Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma Clinical Biochemistry. 33: 579-583. PMID 11124344 DOI: 10.1016/S0009-9120(00)00182-X  1
2000 Foussias G, Yousef GM, Diamandis EP. Molecular characterization of a Siglec8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec8 gene Biochemical and Biophysical Research Communications. 278: 775-781. PMID 11095983 DOI: 10.1006/bbrc.2000.3866  1
2000 Diamandis EP, Yousef GM, Clements J, Ashworth LK, Yoshida S, Egelrud T, Nelson PS, Shiosaka S, Little S, Lilja H, Stenman UH, Rittenhouse HG, Wain H. New nomenclature for the human tissue kallikrein gene family. Clinical Chemistry. 46: 1855-8. PMID 11067830  1
2000 Yousef GM, Magklara A, Diamandis EP. KLK12 is a novel serine protease and a new member of the human kallikrein gene family - Differential expression in breast cancer Genomics. 69: 331-341. PMID 11056051 DOI: 10.1006/geno.2000.6346  1
2000 Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications Clinical Biochemistry. 33: 369-375. PMID 11018688 DOI: 10.1016/S0009-9120(00)00145-4  1
2000 Yousef GM, Chang A, Scorilas A, Diamandis EP. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4 Biochemical and Biophysical Research Communications. 276: 125-133. PMID 11006094 DOI: 10.1006/bbrc.2000.3448  1
Show low-probability matches.